AFC Agro Biotech Limited announcements
258 Dhaka Stock Exchange announcements for AFC Agro Biotech Limited (AFCAGRO) since 2014: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (28).
- Prohibition on providing loan facilities to purchase securities
DSE NEWS: The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of AFC Agro Biotech Ltd. in between 1st to 30th trading day after change of categorization, with effect from December 26, 2021 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.
- Category Change
The Company has been placed in 'B' category from existing 'A' category with effect from December 26, 2021 as the Company has approved 0.50% Cash dividend (other than Sponsors and Directors) for the year ended on June 30, 2021.
- National Credit Ratings Limited (NCR) has announced the surveillance rating of the Company as \"A\" in the long term and
National Credit Ratings Limited (NCR) has announced the surveillance rating of the Company as \"A\" in the long term and \"ST-3\" in the short term along with a developing outlook based on audited financial statements of June 30, 2021.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.29 for July-September 2021 as against Tk. 0.07 for July-September 2020; NOCFPS was Tk. (1.52) for July-September 2021 as against Tk. 2.28 for July-September 2020. NAV per share was Tk. 18.30 as on September 30, 2021 and Tk. 18.00 as on June 30, 2021.
- Resumption after record date
Trading of the shares of the Company will resume on 29.11.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2021.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 24.11.2021 to 25.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 28, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021
- The auditor of the AFC Agro Biotech Ltd has given the \"Qualified Opinion\" & \"Emphasis of matter\" paragraphs in the A
The auditor of the AFC Agro Biotech Ltd has given the \"Qualified Opinion\" & \"Emphasis of matter\" paragraphs in the Auditor\'s Report for the year ended on 30 June, 2021. Basis for Qualified Opinion: 1. Provision for current income tax and deferred tax required as per Para 12 & 15 of IAS 12 has not been made except for other income, as disclosed in note # 14 & 16, based on gazette No- 26.00.0000.100.42.008.17-54 dated 14-05-2018 by Commerce Ministry under the (cont.1)
- (Continuation news of AFCAGRO): captioned \"National Active Pharmaceutical Ingredients (API) & Laboratory Reagents Produ
(Continuation news of AFCAGRO): captioned \"National Active Pharmaceutical Ingredients (API) & Laboratory Reagents Production and Export Policy\" in regard to tax exemption against which relevant S.R.O. No-316-Act/Income Tax/2021 dated 11 October, 2021 from National Board of Revenue (NBR) has obtained by the company. But some conditions of said SRO has yet to be complied with by the company to make effective Tax exemption. (cont.2)
The first part of this announcement is missing from the archive. - (Continuation news of AFCAGRO): No proper disclosure has been made in accordance with Para 46 & Para 81(c) of IAS-12 the
(Continuation news of AFCAGRO): No proper disclosure has been made in accordance with Para 46 & Para 81(c) of IAS-12 the company did not comply with VAT & Tax related provisions/sections of ITO ordinance 1984 and VAT & SD Act-2012 including compliance of IAS-12 by virtue of above gazette notification of commerce ministry & above SRO from NBR. 2. According to Para-9 of IAS-36, An Entity shall assess at the end of each reporting period whether there is any indication (cont.3)
The first part of this announcement is missing from the archive. - (Continuation news of AFCAGRO): that an asset may be impaired. If any such indication exists, the entity shall estimate
(Continuation news of AFCAGRO): that an asset may be impaired. If any such indication exists, the entity shall estimate the recoverable amount of the asset. But the company did not provide any information regarding the assessment of any indication of impairment. 3. Cash at banks includes some uncleared cheques amounting to Tk. 31,667,699 which are shown in the reconciliation statements as \"uncleared lodgement\" but till our reporting date those cheques were not cleared. (cont.4)
The first part of this announcement is missing from the archive. - (Continuation news of AFCAGRO): 4. The company has made significant related party transaction without complying BSEC Not
(Continuation news of AFCAGRO): 4. The company has made significant related party transaction without complying BSEC Notification No. SEC/CMRRCD/2006-159/Admin/02-10 dated September 10, 2006. & SEC/CMRRCD/2008-183/Admin/03-30 dated June 1, 2009. 5. As disclosed in note no. 17.01 of notes to the financial statements, the company paid Tk. 33,425,000 to it\'s workers but the Section 242- in regard to Investment of Participation Fund of the Bangladesh Labour (cont.5)
The first part of this announcement is missing from the archive. - (Continuation news of AFCAGRO): Act-2006 (as amendments up to 2013) was not complied with. Emphasis of Matters: 1. Signi
(Continuation news of AFCAGRO): Act-2006 (as amendments up to 2013) was not complied with. Emphasis of Matters: 1. Significant deviation in Earning per Share (EPS): EPS for the year ended on 30 June 2021 is comes Tk. 0.15 whereas it was Tk. 0.32 for the same period of the previous year registering 53.13\% decrease in current year as compared to the previous year. This was mainly significant fall in the business income due to COVID-19 impact. (cont.6)
The first part of this announcement is missing from the archive. - Qualified Opinion & Emphasis of matter
(Continuation news of AFCAGRO): Our opinion is not modified in respect of this matter. 2. Analysis of accounts receivable and related cash flow reveals that a major portion of earlier year (s) remain uncollected and no expected credit loss has been recognized following IFRS-15. (end)
The first part of this announcement is missing from the archive. - The Board of Directors has recommended 0.50% Cash dividend (other than Sponsors and Directors) for the year ended on Jun
The Board of Directors has recommended 0.50% Cash dividend (other than Sponsors and Directors) for the year ended on June 30, 2021. Total paid up number of shares is 115,216,200 nos. and General Shareholders holding is 80,317,213 nos. of shares and Directors are holding 34,898,987 nos. of shares. Taka 4,015,860.65 will be payable as dividend. (cont.)
- Dividend Declaration
(Cont. of AFCAGRO): Date of AGM: December 23, 2021, Time: 9:30 AM, Venue: Digital Platform. Record Date: November 28, 2021. The Company has reported EPS of Tk. 0.15, NAV per share of Tk. 18.00 and NOCFPS of Tk. 0.17 for the year ended on June 30, 2021 as against Tk. 0.32 Tk. 17.85 and Tk. 2.28 respectively for the same period of the previous year.(end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (31.10.2021) following its corporate declaration.
- The Company has informed that Memorandum of Understanding has been signed between The Centre for Advanced Research in Sc
The Company has informed that Memorandum of Understanding has been signed between The Centre for Advanced Research in Sciences and AFC Agro Biotech Limited, JND Biotech and Emergent Biotech (Two USA Biotech Company) on Covid-19 vaccine (titled as DUBD-Vac) and other infectious diseases related research & development under the proposed \"Biotechnology Research Collaboration\".
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2021 at 12:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- Approval for supplying of RT- PCR Test Kit
Refer to their earlier news disseminated by DSE on 16.02.2021 regarding Authorization Certificate from DGDA, the Company has further informed that they have been awarded Notification of Award (NOA) by the Ministry of Health & Family Welfare for supplying of RT- PCR Test Kit with VTM and Swab Stick for 5, 00,000 (Five Lac) Units. Earlier they were getting the license of producing this RT-PCR Test Kit and now the Company are going to supply the product. The value of the goods in BDT 43,45,00,000.00.
- Query Response
In response to a DSE query dated July 27, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- (Q3 Un-audited): EPS was Tk. 0.03 for January-March 2021 as against Tk. 0.20 for January-March 2020; EPS was Tk. 0.12 fo
(Q3 Un-audited): EPS was Tk. 0.03 for January-March 2021 as against Tk. 0.20 for January-March 2020; EPS was Tk. 0.12 for July 2020-March 2021 as against Tk. 1.01 for July 2019-March 2020. NOCFPS was Tk. 0.43 for July 2020-March 2021 as against Tk. 2.20 for July 2019-March 2020. NAV per share was Tk. 17.97 as on March 31, 2021 and Tk. 17.85 as on June 30, 2020. (cont.)
- (Continuation news of AFCAGRO): The Company has also informed that EPS has been fall down due to decrease in profit from
(Continuation news of AFCAGRO): The Company has also informed that EPS has been fall down due to decrease in profit from comparative quarter. NOCFPS has been significant down in this quarter for increase of receivable from past. (end)
The first part of this announcement is missing from the archive. - As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 8, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.
- Authorization Certificate from DGDA
The Company has informed that they have obtained Emergency Use Authorization (EUA) Certificate from Directorate General of Drug Administration letter dated on February 09, 2021 for producing 2 kits namely (1) AFC Detec nCoV RT-PCR Kit and (2) AFCPrep Viral RNA Extraction Kit. Considering the matter, AFC Agro Biotech Limited will go for commercial production of above mentioned products as early as possible.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.03 for October-December 2020 as against Tk. 0.31 for October-December 2019; EPS was Tk. 0.09 for July-December 2020 as against Tk. 0.81 for July-December 2019. NOCFPS was Tk. 0.45 for July-December 2020 as against Tk. 2.13 for July-December 2019. NAV per share was Tk. 17.95 as on December 31, 2020 and Tk. 17.85 as on June 30, 2020.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.